PDIA3 promotes the occurrence of IBS visceral hypersensitivity through regulating the antigen presentation of DC to mediate an abnormal immune response of CD4+/CD8+ T lymphocytes and MC. Here, PDIA3 is linked to irritable bowel syndrome.